Except for direct surgical palpation of a regurgitant jet the only direct and wholly objective means for demonstrating mitral insufficiency is by opacification and radiography of the cardiac chambers.

The Food and Drug Administration (FDA) has approved Lumason (sulfur hexafluoride lipid-type A microspheres; Bracco Diagnostics Inc.), an ultrasound enhancing agent, for use in echocardiography to ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved perflutren lipid microsphere injection to improve ultrasound imaging in pediatric patients. The ...

Focused cardiac ultrasonography is a point-of-care, qualitative or semiquantitative means of assessing cardiac size, structure, and function that is performed and interpreted by the clinician at the ...